Success Stories

PERIOCHIP

PerioChip is a small, orange brown, rectangular chip (round at one end) for insertion into periodontal pocket.
The active ingredient of PerioChip is Chlorhexidine, a gold standard broad – spectrum antimicrobial agent. Each chip contains 2.5 mg chlorhxidine.
PerioChip is indicated as an adjunct to scaling and root planing procedures for reduction of pocket depth in patients with chronic eiodontitis. PerioChip should be inserted in pockets, 5-8mm in depth. After insertion into the pocket, PerioChip demonstrates a sustained release of chlorhexidine over a period of up to 7-10 days. After that period the PeriChip biodegrades and disappear. The chlorhexidine released from the Periochip have been shown to suppress pocket flora till up to 11 weeks.


Product developed by; Michael Friedman, School of Pharmacy, Michael Sela, Doron Steinberg from the Faculty of Dental Medicine, Hebrew University (Yissum) & Aubrey Soskolne, Faculty of Dental Medicine (Hadasit)
http://www.periochip.com/

Rebif ®

(Recombinant interferon beta), identical to the native molecule and registered for the treatment of multiple sclerosis and several viral diseases, licensed to Inter-Lab Ltd., a Serono company (Yeda).

XenneX, Inc

XenneX, Inc. is a dynamic privately held company that is dedicated to providing Biotechnology, Pharmaceutical and other life sciences companies, as well as organizations dealing with biotechnology intellectual property, the highest level of services and tools to enhance their bio-medical research.
XenneX’ products help such organizations to optimize their efforts to develop innovative medical products and services. Founded in 2003, XenneX operations worldwide are carried out from its offices in Massachusetts, USA.

XenneX’ customers include many of the world’s leading biotech and pharmaceutical companies, located in North America, Europe and Japan. XenneX’ products are used in hundreds of commercial and academic organizations by thousands of users around the globe. (Yeda)